|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| Descriptive Information Fields | |||||
| Brief Title † | Telmisartan+HCTZ, Hypertension | ||||
| Official Title † | PMS Study of MicardisPlus Tablet | ||||
| Brief Summary | This PMS study aims to review the followings by investigating the actual practice of MicardisPlus Tablet on the market:
|
||||
| Detailed Description | |||||
| Study Phase | Phase IV | ||||
| Study Type † | Observational | ||||
| Study Design † | |||||
| Primary Outcome Measure † | |||||
| Secondary Outcome Measure † | |||||
| Condition † | Hypertension | ||||
| Intervention † | |||||
| MEDLINE PMIDs | |||||
| Links | |||||
| Recruitment Information Fields | |||||
| Recruitment Status † | Completed | ||||
| Enrollment † | 7000 | ||||
| Start Date † | |||||
| Completion Date | February 2009 | ||||
| Eligibility Criteria † | Inclusion Criteria: patients diagnosed as essential hypertension Exclusion Criteria: n/a |
||||
| Gender | Both | ||||
| Ages | |||||
| Accepts Healthy Volunteers | No | ||||
| Contacts †† | |||||
| Location Countries † | Korea, Republic of | ||||
| Administrative Information Fields | |||||
| NCT ID † | NCT00659607 | ||||
| Organization ID | 502.475 | ||||
| Secondary IDs †† | |||||
| Study Sponsor † | Boehringer Ingelheim Pharmaceuticals | ||||
| Collaborators †† | |||||
| Investigators † |
|
||||
| Information Provided By | Boehringer Ingelheim Pharmaceuticals | ||||
| Verification Date | November 2008 | ||||
| First Received Date † | April 10, 2008 | ||||
| Last Updated Date | November 18, 2008 | ||||